Malaria in Pregnancy Consortium

Search

  • Home
  • About
    • Our stakeholders
    • The MiP Secretariat
    • Partners
    • Principal Investigators
  • Themes
    • Prevention Africa
      • IPTp Effectiveness multicentre study
      • IST versus IPTp with SP in West Africa
      • New Drugs for IPTp
      • Prevention Malawi – ISTp versus IPTp-SP
    • Prevention Asia and Latin America
      • Prevention Latin America
      • Prevention Strategy for Papua New Guinea
      • Prevention strategy in India
    • Public Health Impact
      • Anthropological studies on malaria in pregnancy
      • Economic studies of malaria in pregnancy interventions
      • Implementation research studies on the access and use of MiP interventions
    • Treatment
      • Treatment Africa
      • Treatment Asia
      • Treatment Latin America
    • Cross cutting areas of research
      • Capacity Development
      • Pathogenesis and Immunity
      • Pharmacokinetics
      • Pharmacovigilance
  • Resources & Peer-reviewed publications
HomeDr Meghna Desai

Dr Meghna Desai

Principal Investigator

Dr Meghna Desai, Deputy Director for Science and CDC Senior Technical Advisor

Treatment Latin America

The efficacy of Artemether-Lumefantrine (Coartem) and Mefloquine-Artesunate for the treatment of uncomplicated P. falciparum malaria parasitemia in pregnant women in Latin America

New Drugs for IPTp

Evaluation of alternative antimalarial drugs to sulfadoxine-pyrimethamine for intermittent preventive treatment in pregnancy (IPTp) in the context of insecticide treated nets

Prevention Latin America

Estimating the burden and impact of malaria in pregnancy in Latin America.

Centers for Disease Control and Prevention

Contact Information

Enquiries
Please contact Tracy Seddon, Programme Coordinator for the MiP Secretariat
Office: +44(0)151 705 3717 Email: tracy [dot] seddon [at] lstmed [dot] ac [dot] uk

A Remora website by Manta Ray Media